Effects of a plasma heating procedure for inactivating ebola virus on common chemical pathology tests

Hong Kong Medical Journal

Volumn 21, Issue 3, 2015, Pages 201-207

  Chong, Y K ^a   Ng, W Y ^a   Chen, Sammy Pl ^a   Mak, Chloe M ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMYLASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE; LACTATE DEHYDROGENASE; MAGNESIUM; TROPONIN I; ENZYME;

ARTICLE; BLOOD ANALYSIS; COMPARATIVE STUDY; CORRELATION COEFFICIENT; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HEMATOLOGICAL PROCEDURE; HUMAN; IMMUNOASSAY; PLASMA HEATING; VIRUS INACTIVATION; BLOOD; HEATING; PHYSIOLOGY;

BLOOD CHEMICAL ANALYSIS; EBOLAVIRUS; ENZYMES; HEATING; HUMANS; VIRUS INACTIVATION;

EID: 84930787455     PISSN: 10242708     EISSN: None     Source Type: Journal    
DOI: 10.12809/hkmj144373     Document Type: Article

References (16)

1. World Health Organization. Disease Outbreak News (DONs) 2014 [12/8/2014]. Available from: http://www. who.int/csr/don/2014_08_11_ebola/en/. Accessed 12 Aug 2014.
2. IHR Emergency Committee Members and Advisers. WHO Statement on the Meeting of the International Health Regulations Emergency Committee Regarding the 2014 Ebola Outbreak in West Africa 2014 [12/8/2014]. Available from: http://www.who.int/mediacentre/news/statements/2014/ebola-20140808/en/. Accessed 12 Aug 2014.
3. Leroy EM, Kumulungui B, Pourrut X, et al. Fruit bats as reservoirs of Ebola virus. Nature 2005;438:575-6.
4. Wilson JA, Hevey M, Bakken R, et al. Epitopes involved in antibody-mediated protection from Ebola virus. Science 2000;287:1664-6.
5. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377:849-62.
6. Kortepeter MG, Martin JW, Rusnak JM, et al. Managing potential laboratory exposure to Ebola virus by using a patient biocontainment care unit. Emerg Infect Dis 2008;14:881-7.
7. Jaax N, Jahrling P, Geisbert T, et al. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet 1995;346:1669-71.
8. Leffel EK, Reed DS. Marburg and Ebola viruses as aerosol threats. Biosecur Bioterror 2004;2:186-91.
9. Sewell DL. Laboratory-associated infections and biosafety. Clin Microbiol Rev 1995;8:389-405.
10. Interim infection prevention and control guidance for care of patients with suspected or confirmed Filovirus haemorrhagic fever in health-care settings, with focus on Ebola 2014. Available from: http://www.who.int/csr/resources/who-ipc-guidance-ebolafinal-09082014.pdf. Accessed 12 Aug 2014.
11. Interim guidance for specimen collection, transport, testing, and submission for patients with suspected infection with Ebola virus disease 2014 [12/8/2014]. Available from: http://www.cdc.gov/vhf/ebola/hcp/interim-guidance-specimencollection-submission-patients-suspected-infection-ebola.html. Accessed 12 Aug 2014.
12. WHO recommended guidelines for epidemic preparedness and response: Ebola haemorrhagic fever (EHF). Geneva: World Health Organization; 1997
13. Bhagat CI, Lewer M, Prins A, Beilby J. Effects of heating plasma at 56 degrees C for 30 min and at 60 degrees C for 60 min on routine biochemistry analytes. Ann Clin Biochem 2000;37:802-4.
14. Hersberger M, Nusbaumer C, Scholer A, Knöpfli V, von Eckardstein A. Influence of practicable virus inactivation procedures on tests for frequently measured analytes in plasma. Clin Chem 2004;50:944-6.
15. Ferry JD, Collins S, Sykes E. Effect of serum volume and time of exposure to gel barrier tubes on results for progesterone by Roche Diagnostics Elecsys 2010. Clin Chem 1999;45:1574-5.
16. Bush V, Blennerhasset J, Wells A, Dasgupta A. Stability of therapeutic drugs in serum collected in vacutainer serum separator tubes containing a new gel (SST II). Ther Drug Monit 2001;23:259-62.